Of note, it was not possible to analyze the ARNTL variant rs117104877, which is highly significantly associated with ovarian cancer risk in the study published by Jim and Colleagues [57], because of the scarcity of datasets. This evidence concerns the gene BMAL1 and ovarian carcinoma.